2025 Guidelines for the Evaluation and Management of Adults With Congenital Heart Disease
December 19, 2025
Brand Name :
Mechlorethamine hydrochloride, Nitrogen mustard, Mustargen, Valchlor
Synonyms :
Mechlorethamine
Class :
Dosing
powder for injection
10mg/vial
Adult dosing
Cancers
Intravenous dosing: Administer 0.4 mg/kg spread out over 2 to 4 days.
Combination therapy (MOPP protocol): Give 6 mg/m² per day intravenously on days 1 and 8, repeated every 4 weeks.
The next treatment cycle should not begin until the white blood cell count exceeds 1000/mm³ and platelet count is above 50,000/mm³.
Metastatic Carcinoma
Intracavitary administration: A single dose of 0.4 mg/kg.
Intrapericardial administration: Administer 0.2 mg/kg as a one-time dose
Safety and efficacy not established
Refer adult dosing
Interaction with mechlorethamine can diminish the therapeutic effect of the vaccine. Live-attenuated Vaccines should be avoided for 3 months after ending immunosuppressive therapy
Interaction with mechlorethamine can diminish the therapeutic effect of the vaccine. Live-attenuated Vaccines should be avoided for 3 months after ending immunosuppressive therapy
Interaction with mechlorethamine can diminish the therapeutic effect of the vaccine. Live-attenuated Vaccines should be avoided for 3 months after ending immunosuppressive therapy
May increase the immunosuppressive effect of abrocitinib
May increase the immunosuppressive effect of barcitinib
May increase the immunosuppressive effect of tofacitinib
The risk of infection is enhanced due to increased immunosuppressive effects of natalizumab.
Risk of infection enhanced due to increased immunosuppressive effects of nivolumab.
Risk of infection enhanced due to increased immunosuppressive effects of ocrelizumab
Risk of infection enhanced due to increased immunosuppressive effects of trastuzumab
Increased risk of immunosuppressant activity may lead to the risk of severe infection
Possibility of increase in renal toxicity if given with mechlorethamine
Higher risk of bone marrow suppression
Involves higher risk of bone marrow suppression
Higher risk of bone marrow suppression
Higher risk of bone marrow suppression
Immunosuppressive effects can lead to the risk of serious infections
when both drugs are combined, there may be an increased risk or severity of adverse effects
may increase immunosuppression and bone marrow suppression by pharmacodynamic synergism
Actions and Spectrum:
Actions:
Mechlorethamine is a biological alkylating agent. It works by changing DNA. It attaches alkyl groups to guanine bases in DNA. This interferes with DNA replication and transcription. This prevents rapidly dividing cells, like cancer cells, from growing and multiplying. Mechlorethamine forms crosslinks between DNA strands and DNA adducts. This damages the DNA’s structure, causing cellular problems and cell death. Rapidly dividing cells are affected the most. This is why mechlorethamine is effective against cancers like lymphoma and Hodgkin’s disease.
Spectrum:
Mechlorethamine is also called Mustargen. It stops cancer cells from growing by attaching to their DNA, stopping them from copying themselves. It was originally made from nitrogen mustard gas used in World War I. Mechlorethamine works against many cancers, like lymphoma. It can be given when cancer cells are growing fast or resting. This makes it strong against quickly dividing cells.
Black Box Warning:
Mechlorethamine injection is given by an oncologist into a vein. It may leak, causing irritation or tissue harm. Your doctor will watch for side effects like pain, redness, itching, blisters, swelling, or sores where injected. If these occur, you must tell your doctor right away.
Contraindication/Caution:
Contraindications
Cautions
Pregnancy Categories:
Pharmacology:
Mechlorethamine is a biological agent that alters cells. It binds the DNA, preventing fast-growing cells from dividing. The hydrochloride form treats cancer: Hodgkin’s disease and lymphoma. Mechlorethamine crosslinks DNA strands, so cells can’t split. This stops the over growth typical in cancers. Though potent, its mechanisms also make it a chemotherapy drug.
Pharmacodynamics:
It creates carbonium ions. Those stop RNA and DNA from being made. Plus, the ions cause breaks between DNA strands. This results in coding mistakes and breaks. In the end, DNA replication is disrupted.
Pharmacokinetics:
Metabolism
Hydrolysis and demethylation happen quickly. These processes break down the drug fast.
Elimination and Excretion
The drug leaves the body in less than one minute. It mainly gets flushed out in urine.
Administration:
Mechlorethamine is a drug powder. Doctors add liquid to it. Then it is given through an IV by a nurse. It may also go into the chest, stomach, or heart lining instead. How long the dosage is given differs.
Patient information leaflet:
Mechlorethamine is a tyrosinase inhibitor. It stops cancer cells from growing. It treats skin cancer and cutaneous T-cell lymphoma. Mechlorethamine is applied to the skin when cold. You must put it back in the fridge within 30 minutes. Side effects are skin irritation, blisters, burning, itching, redness, tenderness, swelling, or skin darkening. Do not eat or drink mechlorethamine. It can harm you. If you miss a dose, take it when you remember. But don’t double dose if almost time for the next one.